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Background: Although the 3T3-L1 preadipocyte cell line represents an informative
model for in vitro adipogenesis research, primary cultured cells are often needed to
understand particular human or animal metabolic phenotypes. As demonstrated by
in vitro cultured preadipocytes from large mammalian species, primary cultured cells
require specific adipogenic differentiation conditions different to that of the 3T3-L1
cell line. These conditions are also species-specific and require optimization steps.
However, efficient protocols to differentiate primary preadipocytes using alternative
species to rodents are scarce. Sheep represent an amenable animal model for fetal
biology and developmental origins of health and disease studies. In this work, we
present with the first detailed procedure to efficiently differentiate primary fetal and
adult ovine preadipocytes.
Methods: Fetal and adult ovine adipose and skin tissue harvest, preadipocyte and
fibroblast isolation, proliferation, and standardization and optimization of a new
adipogenic differentiation protocol. Use of commercial cell lines (3T3-L1 and NIH-3T3)
for validation purposes. Oil red O stain and gene expression were used to validate
adipogenic differentiation. ANOVA and Fisher’s exact test were used to determine
statistical significance.
Results: Our optimized adipogenic differentiation method included a prolonged
adipogenic cocktail exposure time from 2 to 8 days, higher insulin concentration, and
supplementation with the peroxisome proliferator-activated receptor gamma (PPARγ)
agonist, rosiglitazone. This protocol was optimized for both, fetal and adult preadipocytes.
Conclusions: Our protocol enables successful adipogenic differentiation of fetal and
adult ovine preadipocytes. This work demonstrates that compared to the 3T3-L1 cell line,
fetal ovine preadipocytes require a longer exposure to the differentiation cocktail, and the
need for IMBX, dexamethasone, and/or the PPARγ agonist rosiglitazone through the
terminal differentiation phase. They also require higher insulin concentration during
differentiation to enhance lipid accumulation and similar to human primary
preadipocytes, PPARγ agonist supplementation is also required for ovine adipogenic
differentiation. This work highlights species-specific differences requirements for
adipogenic differentiation and the need to develop standardized methods to investigate
comparative adipocyte biology.
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To study adipogenesis, adipogenic differentiation, and their regulation, investigators
often resource to the commercially available preadipocyte cell line 3T3-L1 of murine
origin [1]. Results from these studies are not as useful for applications on human health
as expected, given the physiological and metabolic differences among species [2].
Human primary cultured cells are the best resource to understand human adipocyte
biology in deranged metabolic states [2], but cannot inform about cell events that occur
during prenatal life. The developmental origins of health and disease theory is pointing
to early life events as one of the contributing factors towards the increased prevalence
of metabolic diseases worldwide, including obesity [3–5]. To test hypotheses relative to
fetal adipose tissue differentiation and fate and/or the effects of prenatal exposures
(chemicals, stress, nutrition) on adult metabolic risk, alternative models are often
needed [6]. Other large mammalian species, such as feline and porcine primary cells,
have recently been used as alternatives [7, 8]. The sheep is an outstanding animal
model to understand how prenatal exposures can affect adult metabolic disease risk
[9–12] because, as humans, sheep are a monotocous and precocial species, with major-
ity of organs maturing before birth [13], including the adipose tissue [14]. Identified
barriers to the advance of our understanding on adipocyte biology include the great
diversity of protocols available for some cell lines and the lack of standardized methods
of adipogenic differentiation in other mammalian species [2]. As we demonstrate in this
study, standard murine 3T3-L1 differentiation protocols [15, 16] are not suitable for
ovine preadipocyte adipogenic differentiation.
Adipocyte differentiation is a complex process by which preadipocytes transition into
lipid-filled, insulin-responsive adipocytes. Adipocyte fate is controlled by transcription
factors, including peroxisome proliferator-activated receptor gamma (PPARγ), CCAAT/
enhancer-binding proteins (C/EBPs), and sterol regulatory element binding protein
(SREBP). Preadipocyte differentiation is routinely initiated by a 48 h exposure to a basic
3T3-L1 differentiation induction cocktail containing 3-isobutyl-1-methyxantine
(IBMX), dexamethasone, and insulin [17]. IBMX regulates C/EBPβ [18], enhances 3T3-
L1 differentiation upon longer exposures [15], and alone [19] or in combination with
dexamethasone [20], regulates PPARγ activity. PPARγ, the master regulator of adipo-
genesis, cooperates with C/EBPα to initiate adipogenic differentiation, is required in
human preadipocyte differentiation [21, 22], and can increase glycerol-3-phosphate
dehydrogenase (GPDH) activity in sheep preadipocytes [23], an enzyme involved in
lipid biosynthesis. PPARγ agonists, such as thiazolidinediones, have been used to
enhance adipogenic differentiation in 3T3-L1 and primary preadipocytes of large mam-
mals [7, 14, 17]. In addition, supplementation with insulin promotes preadipocyte dif-
ferentiation [24], but the insulin dose is among the most variable media components of
3T3-L1 differentiation protocols [17].
In this work, we aimed to standardize a protocol for effective ovine adipogenic differ-
entiation using fetal and adult primary cultured preadipocyte that will help understand
basic adipocyte biology knowledge in a relevant meat-producing species, as well as
events occurring during fetal adipose tissue remodeling. To enable ovine adipogenic
differentiation, we applied several media modifications. Here, we have only presented
the key modifications that resulted in significant improvements in ovine preadipocyte
adipogenic differentiation.
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Fetal and adult tissue harvest
All procedures used in this study were approved by the Institutional Animal Care and
Use Committee of Michigan State University (MSU) and are consistent with the
National Research Council’s Guide for the Care and Use of Laboratory Animals and
the Animal Welfare Act. The study was conducted at the MSU Research Facility (East
Lansing, MI; 42.7° N, 84.4° W) using an in-house flock of multiparous Polypay x
Dorsett breed of sheep. Female sheep were bred using a time mated pregnancy strategy.
At gestational day 120 and after humane sacrifice, fetal perirenal adipose tissue and
skin from the abdominal midline were harvested from female fetuses to isolate fetal
ovine preadipocytes (oPADs) and skin fibroblasts. Immediately after, tissues were placed
in transport medium (Omental Preadipocyte Medium, Zen Bio, USA) and processed
within two hours. Adipose tissue was also collected from the subcutaneous adipose
depot of three adult females after humane sacrifice.Generation of fetal and adult ovine primary preadipocytes
Preadipocyte isolation method was conducted following a common standard protocol
used in isolation of human adipogenic precursor cells [25]. This isolation protocol
followed by adipogenic differentiation allows an average cell differentiation rate of 50-60%
[25]. In brief, fetal and adult oPADs were isolated by rinsing a 1–2 g of adipose tissue with
pre-warmed Dulbecco’s phosphate-buffered saline (DPBS) with antibiotic-antimycotic
(Invitrogen), removing any visible blood clots and connective tissue using sterile forceps
and then minced into small pieces. Collagenase-I (C0130, Sigma, 1 mg/ml) was used to
digest tissue for 40 min in a 37 °C water bath. The mixture was filtered through a mesh
filter (250 μm, U-CMYBK-250, Component Supply Company, Fort Meade, USA) and
centrifuged at 1,200 rpm for 5 min. The cell pellet was washed with fresh omental
preadipocyte medium and seeded into 6-well plates. After six days of culture, cells
were frozen (Preadipocyte Cryopreservation Medium, FM-1-100, Zen-Bio) and stored
in liquid nitrogen until further use. All experiments were performed using fetal oPAD
primary cells (passage 3) from one female and validated with fetal and adult oPADs
from 2 and 3 additional females, respectively. The 3T3-L1 (preadipocyte) and NIH-
3T3 (fibroblastic) cell lines were used as positive and negative control of adipogenic
cells, respectively. Ovine fetal primary fibroblasts were also used as a negative control
of adipogenesis.Generation of fetal ovine primary skin fibroblasts
Ovine fetal primary fibroblasts were isolated as follows. After hair and connective tis-
sue removal using sterile forceps, fetal skin tissue was rinsed twice with pre-warmed
DPBS supplemented with antibiotic and antimycotic. Tissue (1 g) was minced into
small pieces and distributed into 6-well plates with 0.2 ml of serum per well. After
6 h incubation, 2 ml of basal medium consisting of DMEM/F12 medium (Invitrogen)
supplemented with 1% penicillin-streptomycin, 10 mM HEPES, and 10% fetal bovine
serum (Corning, Manassas, VA, USA) was added into the plate and primary cells cul-
tured for 4 to 6 days until confluency. Cells were then trypsinized and passaged as
primary fibroblasts for further study.
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Primary cultured oPADs were trypsin digested (Invitrogen, 0.05%) for subculture upon
90% confluency. Proliferation ability for each cultured cell (passage 3) was assessed by
growth curve analysis. Cells were seeded at a density of 10,000 cells per well in 24-well
plates and the counts were performed in haemocytometer chamber. Cell counts were
performed every 24 h for 8 days. Triplicate wells for each time point per cultured cell
were used.Cell culture and adipocyte differentiation
Before differentiation induction, fetal oPADs (passage 3), 3T3-L1 cells (American Type
Culture Collection, ATCC, Manassas, VA, USA; within passage 6), and NIH-3T3
(ATCC, Manassas, VA, USA; within passage 6) were cultured in basal medium (same
as for oSFs) until confluency and allowed to grow for two additional days. Thereafter,
adipocyte differentiation was induced. Summary of adipogenic differentiation media
and exposure times are detailed in Figs. 1c and 2c. 3T3-L1 differentiation medium 1a
(DM1a) consisted of basal medium supplemented with biotin (33 μM), pantothenate
(17 mM), insulin (1 μg/ml), dexamethasone (1 μM) and 3-isobutyl-1-methylxanthine
(IBMX, 0.5 mM). 3T3-L1 differentiation medium 1b (DM1b) was same as DM1a, with-
out dexamethasone and IBMX. 3T3-L1 were exposed to DM1a from days 0 to 2 and to
DM1b from days 3 to 8 (Fig. 1c). All media were replaced every 48 h. Composition of
the modified differentiation medium 2a (DM2a) was the same as DM1a, but supple-
mented with increased insulin concentration (10 μg) and rosiglitazone (20 μM). Differ-
entiation medium 2b (DM2b) was the same as DM2a, but without dexamethasone,
IBMX, and rosiglitazone (Fig. 2c). Rosiglitazone concentration was based on previous
reports [26] and pilot work in our laboratory (data not shown). Ovine female fetal skin
fibroblasts were induced to differentiate using the final differentiation protocol to dem-
onstrate how ovine fetal fibroblasts lack the ability to differentiate upon exposure to
the PPARγ agonist, rosiglitazone (Fig. 3c). 3T3-L1 and NIH-3T3 cell lines were also in-
duced to differentiate (Fig. 3c) in DM1a media for 2 days, following by DM1b media
for additional 6 days.Oil Red O stain
Preadipocyte differentiation into mature adipocytes was determined by Oil Red O (ORO)
stain, as a marker of lipid accumulation. In brief, ORO (0.3%) was dissolved in isopropanol
diluted in water (0.18%). Adipocytes at differentiation day 8, were washed with DPBS
twice then fixed in 10% formalin for 30 min at room temperature. Cells were washed with
DPBS and incubated 5 min in 60% isopropanol followed by incubation in ORO working
solution. After multiple DPBS washes, bright field images were captured on an inverted
microscope. Five images of each treatment were used to calculate ORO positive area using
the Image J software [27].Quantitative real time PCR (qRT-PCR)
To evaluate the dynamic expression of genes involved in adipogenic differentiation,
qRT-PCR (ABI-Quant Studio 7 Flex Real-Time PCR System, Thermo Fisher, Carlsbad,
CA) was performed to examine the mRNA expression of ovine genes encoding for
ac
b
Fig. 1 Differentiated 3T3-L1 cells and fetal ovine preadipocytes (oPADs) with 3T3-L1 medium. Quantification
of ORO positive area (mean ± SEM; a), representative ORO stain images of 3T3-L1 (B1) and fetal oPADs (B2)
after 8 days of differentiation (b), and differentiation medium details (c). Scale bar: 50 μm. BM: basal
medium, Dex: dexamethasone, DM: differentiation medium, Ins: insulin, oPADs: ovine preadipocytes, Rosi:
rosiglitazone. Three fetal oPAD primary cells (passage 3) from three different fetuses were used. Asterisk
represents significant differences (P < 0.05)
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tein 4 (FABP4), CCAAT/enhancer-binding protein alpha (C/EBPα), adiponectin
(ADIPOQ), protein delta homolog 1 (DLK1) and zinc finger protein 423 (ZFP423).
Primer sequences are shown in Table 1. The sizes of the DNA templates were con-
firmed by 1.5% agarose gel. Cultured cells were washed three times with ice cooled
DPBS and total RNA extracted with an RNeasy Mini kit (Qiagen, Hilden,
Germany) according to the manufacturer’s protocol. RNA quality and concentration
were measured by Nanodrop (Thermo Fisher Science, Wilmington, NC, USA).
1 μg RNA (quality: A260/A280: 2.0 ± 0.05; concentration: 200 ± 50 ng/μl) was re-
verse transcribed into cDNA using a High Capacity cDNA Reverse Transcription
Kit (Promega, Madison, WI, USA) in 10 μl reaction volume. cDNA amplification
reaction (50 ng) consisted of template denaturation and polymerase activation at
95 °C for 30 s, followed by 40 cycles of denaturation at 95 °C for 15 s, annealing
at 60 °C for 30 s, and extension at 72 °C for 30 s. All experiments and qRT-PCR
were run in triplicate. Melt curve analyses were performed for all genes, and the
specificity as well as integrity of the PCR products was confirmed by the presence
of a single peak. The levels of mRNA encoding the indicated genes were normal-
ized against three housekeeping genes GAPDH, RPL27, and β-actin to calculate
relative fold change to that of the control. Results using all three housekeeping
genes provided with the same results, but only GAPDH data are shown.
ac
b
Fig. 2 Effect of rosiglitazone supplementation and prolonged adipogenic cocktail exposure on ovine fetal
and adult preadipocyte (oPADs) differentiation. Quantification of ORO positive area (mean ± SEM; a),
representative ORO stain images of fetal (B1 (only insulin supplementation in days 3 to 8); B2 (optimized
medium)) fetal and adult oPADs (B3; optimized medium) after 8 days of differentiation (b), and differentiation
medium details (c). Scale bar: 50 μm. BM: basal medium, Dex: dexamethasone, DM: differentiation medium, Ins:
insulin, oPADs: ovine preadipocytes, Rosi: rosiglitazone. Three fetal oPADs and three adult oPADs primary cells
(passage 3) from three different fetuses and three different adult sheep, respectively, were used. Asterisks
represent significant differences (P < 0.05)
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All data are presented as mean ± SEM. All experiments (adipogenic differentiation in
fetal and adult oPADs and oSFs, and qRT-PCR) were conducted in triplicate. Appropri-
ate transformations were applied, as needed, to account for normality of data. ANOVA
was used to compare gene expression data among differentiation time points followed
by Dunnett’s posthoc test. For comparing percent differences Fisher’s exact test was
used. Statistical software used was PASW Statistics for Windows release 18.0.1. Differ-
ences were considered significant at P < 0.05.
Results and discussion
In this work, we have successfully established a protocol to induce adipogenic differen-
tiation in fetal and adult ovine primary cultured preadipocytes. As expected from prea-
dipocytes, the morphology of oPADs was phenotypically fibroblastic (Fig. 4a-b),
demonstrated good proliferative ability (Fig. 4c), and expressed both, the preadipocyte
marker (DLK1) [28] and the adipogenic differentiation ability marker (ZFP423) [29]
mRNA (Fig. 3a). ZFP423 mRNA expression was highest in the 3T3-L1 cell line (100%,
preadipocyte cell line), followed by oPADs (71%), ovine fetal primary fibroblasts (17%)
and NIH-3T3 cell line (0.5%, fibroblast cell line) and was positively correlated with the
differentiation ability of each of these cultured cells and cell lines (Fig. 3b-c).
We first tested the ability of the 3T3-L1 differentiation protocol (Fig. 1c) to induce differ-
entiation in fetal oPADs and compared it to the differentiation ability in the 3T3-L1 cell
line (Fig. 1). After 8 days of differentiation, over 90% of 3T3-L1 cells differentiated in fully
mature adipocytes as shown by ORO stain (Fig. 1a and b1). However, the 3T3-L1 protocol
ac
b
Fig. 3 Preadipocyte and adipogenic markers mRNA expression in murine and ovine primary cultured cells
and cell lines. a) DLK1 and ZFP423 mRNA expression in ovine fetal preadipocytes (oPADs). b ZFP423 mRNA
expression in undifferentiated 3T3-L1 and NIH-3T3 cell lines and fetal ovine primary cultured cells, oPADs
and fetal skin fibroblasts (oSFs). c Oil red O stain of 3T3-L1 cell line (preadipocyte), NIH-3T3 cell line (fibroblast),
ovine female fetal preadipocytes (oPADs), and skin fibroblasts (oSFs) after differentiation induction for 8 days.
Three fetal oPADs and three fetal oSFs primary cells (passage 3) from three different fetuses were used
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≥ 16-fold difference between 3T3-L1 and fetal oPADs differentiation was similar to reports
standardizing adipogenic differentiation with human primary preadipocytes [22, 30].
Because insulin concentration is among the adipogenic media supplements with the
largest variation [17], we tested if increasing the insulin concentration would improve
accumulation of lipid droplets during adipogenic differentiation. A 10-fold increase in
insulin concentration (10 μg/ml) induced the formation of small and middle-sized lipid
droplets in fetal oPADs (data not shown). 3T3-L1 cells do not require adipogenic in-
duction with a PPARγ agonist, however differentiation protocols for large mammalian
species [7, 8, 14] preadipocyte and human mesenchymal stem cells into adipocytes
often include this modification [31, 32]. To test if supplementation with a PPARγ
a c
b
Fig. 4 Characterization of primary fetal ovine preadipocytes (oPADs). oPADs in culture (a) and at confluency
(b). c Preadipocytes growth curve (mean ± SEM) over 8 days (three fetal oPADs cell lines)
Table 1 Primers for quantitative real time PCR
Gene Primer Length (bp) Accession number
oADIPOQ - Forward GGAGATCCAGGTCTCGTTGG 98 NM_001308565
oADIPOQ - Reverse TTTCTGCCTGGGACTCCTGG
oβ-ACTIN - Forward CCAACCGTGAGAAGATGACC 97 NM_001009784
oβ-ACTIN - Reverse CCAGAGGCGTACAGGGACAG
oC/EBPα - Forward CCCCGACAGGAGCAAGGT 114 KF830871
oC/EBPα - Reverse GGTTCAAAGCCCCAAGT
oDLK1 - Forward GGCATCGTCTTCCTCAAC 89 XM_015102053
oDLK1 - Reverse CGCAGCAGCAGATTCTTC
oFABP4 - Forward GGATGATAAGCTGGTGCTGG 53 NM_001114667.1
oFABP4 - Reverse CTCTGGTAGCAGTGACACCG
oGAPDH - Forward TTCCACGGCACAGTCAA 241 NM_001190390
oGAPDH - Reverse TCACGCCCATCACAAAC
mGAPDH - Forward CGGCAAATTCAACGGCACA 84 NM_001289726
mGAPDH - Reverse TCTCGCTCCTGGAAGATGG
oPPARγ - Forward TGGATGACCACTCCCATGCC 97 NM_001100921
oPPARγ - Reverse TTGGGAACGGAATGTCCTC
oRPL27 - Forward CGCAAGGCCCGACGAGAGGC 93 XM_015098799
oRPL27 - Reversr GACCTAAAACCGCAGCTTCTGG
oZFP423 - Forward CCCGATTCCAGCAACCACA 160 XM_015100428
oZFP423 - Reverse CGTCATCCCGCATCTTCTTCT
mZFP423 - Forward CCGTCTGCTTCACAGTCTTCG 155 NM_001310520
mZFP423 - Reverse TGCGTGCTGGCTCATCG
Note: o refers to ovine, m refers to murine. Accession number from NCBI gene database
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Fig. 5 Dynamic gene expression in fetal ovine preadipocytes (oPADs) during differentiation. mRNA
expression (mean ± SEM) through adipogenic differentiation in fetal oPADs from day 0 to 7 of
differentiation when using the optimized differentiation protocol (Fig. 2b2). Different letters represent
significant differences (P < 0.05) within gene and between culture days by ANOVA. Three fetal oPAD
primary cells (passage 3) from three different fetuses were used. Gene expression was validated using three
housekeeping genes (GAPDH, RPL27, and β-actin), but only GAPDH results are shown
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selected over other PPARγ agonists, such as troglitazone, because troglitazone is only a
partial PPARγ agonist [33]. Rosiglitazone (20 μM) was included into the differentiation
medium (DM2a; Fig. 2c) and cells exposed for 2 days. Thereafter, differentiation
medium was replaced with DM2b (Fig. 2c) and fetal oPADs cultured for 6 additional
days. Addition of a PPARγ agonist for 48 h improved differentiation, increasing
medium-sized lipid droplet formation (Fig. 2b1) and suggesting that similar to feline
[7], porcine [34], and human [31] preadipocytes, ovine preadipocytes have lower sensi-
tivity to insulin than murine cell lines and PPARγ agonist may be a more stringent re-
quirement for adipogenic differentiation in these species.
Since previous studies have shown that longer exposure (>2 days) to the differenti-
ation cocktail can enhance adipogenesis [35, 36], we tested if a longer exposure to the
DM2a increased ovine adipogenic differentiation. Exposure to the DM2a for 8 days
resulted in an enhanced adipogenic differentiation of oPADs and formation of medium
to large sized lipid droplets (Fig. 2b2). With this differentiation protocol, lipid accumu-
lation is readily visible under light microscope starting at day 3 of culture. The final
protocol (8 days of DM2a exposure) was tested in two additional fetal oPADs confirm-
ing differentiation results observed in the first fetal oPAD cultured cells. We also tested
our optimized adipogenic differentiation system in three different ovine adult primary
cultured preadipocytes. Adult subcutaneous preadipocytes were used and a similar
differentiation rate to that seen in fetal oPADs was observed (Fig. 2a and b3). Because
PPARγ agonists can induce lipid droplet accumulation in non-adipogenic cells, we used
ovine fetal skin fibroblasts to test if rosiglitazone could induce lipid droplet accumula-
tion. Fetal fibroblasts originated from the same animals as the oPADs. When subjected
to the final protocol (DM2a for 8 days), fetal fibroblasts were not able to accumulate
lipid droplets (Fig. 3c).
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of genes expressed in preadipocytes (DLK1) and in the commitment (C/EBPα and
PPARγ) and terminal phase (FABP4 and ADIPOQ) of adipogenesis by qRT-PCR. Differ-
entiation was confirmed by a downregulation of DLK1 and exponential upregulation of
C/EBPα, PPARγ, FABP4, and ADIPOQ (Fig. 5) upon differentiation progression.
In conclusion, our protocol enables successful adipogenic differentiation of fetal and
adult ovine preadipocytes. It also demonstrates that compared to the 3T3-L1 cell line,
fetal ovine preadipocytes require a longer exposure to the differentiation cocktail, and
suggests the need for IMBX, dexamethasone, and/or the PPARγ agonist rosiglitazone
through the terminal differentiation phase. They also require higher insulin concentra-
tion during differentiation to enhance lipid accumulation and similar to human primary
preadipocytes [21, 22], PPARγ agonist supplementation is also required for ovine adipo-
genic differentiation. This work highlights species-specific differences requirements for
adipogenic differentiation [7, 14, 31, 34] and the need to develop standardized methods
to investigate comparative adipocyte biology.
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